Product Description:
Metformin Hydrochloride Sustained Release & Miglitol Bilayer Tablets 500 mg + 25 mg is a combination oral medication used in the treatment of type 2 diabetes mellitus. This combination provides dual benefits in managing blood sugar levels effectively.
Metformin Hydrochloride is a biguanide that works by reducing the amount of glucose produced by the liver and improving the body's sensitivity to insulin. The sustained-release formulation ensures a gradual release of the medication over time, helping maintain consistent blood glucose control throughout the day while minimizing side effects, such as gastrointestinal discomfort.
Miglitol is an alpha-glucosidase inhibitor that works by slowing the breakdown of carbohydrates in the intestines, leading to slower absorption of glucose from meals. This helps prevent sharp spikes in blood sugar after eating.
This combination tablet helps control blood glucose levels both by reducing the amount of sugar produced by the liver and by slowing the absorption of glucose, especially after meals.
Uses:
Treatment of type 2 diabetes mellitus
Helps lower blood sugar levels by improving insulin sensitivity and slowing glucose absorption from food
Can be used as part of a comprehensive diabetes management plan, including diet and exercise
